Patients With Severe Hereditary Angioedema Treated With Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) to Reduce the Incidence and Severity of Attacks: Results From a Phase 3 Trial
Sign Up to like & getrecommendations! Published in 2018 at "Pediatrics"
DOI: 10.1542/peds.142.1_meetingabstract.812
Abstract: Background: Hereditary angioedema (HAE), caused by absolute or functional deficiency of C1-esterase inhibitor (C1-INH), is characterized by recurrent, disfiguring, and potentially life-threatening attacks of subcutaneous and submucosal edema. The mean age of first attack is… read more here.
Keywords: phase trial; hereditary angioedema; inhibitor inh; esterase inhibitor ... See more keywords